Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In summary, to address the multidimensional challenges of ADC resistance, scientific research and clinical practice are concurrently advancing innovations in molecular optimization and strategy integration
By leveraging their unique mechanism of action, HDACi opens new avenues for enhancing antitumor immunity and achieving durable therapeutic responses
FOXO4-DRI is a first-in-class senolytic peptide that selectively eliminates senescent "zombie cells" by disrupting the FOXO4-p53 interaction
Zinc transport differs in rat spermatogenic cell types and is affected by treatment with cyclophosphamide
adults showed 13% have used a GLP-1 medication
US$ 27.61
US$ 29.35
US$ 25.17
US$ 23.59
US$ 28.56
US$ 27.81
US$ 25.01
US$ 27.47
